hexachlorophene has been researched along with vancomycin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bao, R; He, L; Ju, Y; Li, C; Luo, Y; Sang, Z; Song, R; Sun, K; Yang, T; Yang, Y; Zhou, Y | 1 |
John, JF; Levkoff, AH; Reboli, AC | 1 |
5 other study(ies) available for hexachlorophene and vancomycin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Boron Compounds; Boronic Acids; Endopeptidase Clp; Female; Glycine; Humans; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Molecular Docking Simulation; Molecular Structure; Peptidomimetics; Protein Binding; Serine Proteinase Inhibitors; Skin; Small Molecule Libraries; Staphylococcal Skin Infections; Structure-Activity Relationship; Virulence | 2020 |
Epidemic methicillin-gentamicin-resistant Staphylococcus aureus in a neonatal intensive care unit.
Topics: Cross Infection; Drug Resistance; Gentamicins; Hexachlorophene; Humans; Infant, Low Birth Weight; Infant, Newborn; Intensive Care Units, Neonatal; Methicillin; Plasmids; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |